-
1
-
-
0035353725
-
Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
-
Ahlskog J.E., Muenter M.D. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov. Disord. 16:2001;448-458.
-
(2001)
Mov. Disord.
, vol.16
, pp. 448-458
-
-
Ahlskog, J.E.1
Muenter, M.D.2
-
2
-
-
0030752606
-
The long-duration action of levodopa may be due to a postsynaptic effect
-
Barbato L., Stocchi F., Monge A., Vacca L., Ruggieri S., Nordera G., Marsden C.D. The long-duration action of levodopa may be due to a postsynaptic effect. Clin. Neuropharmacol. 20:1997;394-401.
-
(1997)
Clin. Neuropharmacol.
, vol.20
, pp. 394-401
-
-
Barbato, L.1
Stocchi, F.2
Monge, A.3
Vacca, L.4
Ruggieri, S.5
Nordera, G.6
Marsden, C.D.7
-
3
-
-
0015745743
-
Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological, and neurochemical correlations
-
Bernheimer H., Birkmayer W., Hornykiewicz O. Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological, and neurochemical correlations. J. Neurol. Sci. 20:1973;415-455.
-
(1973)
J. Neurol. Sci.
, vol.20
, pp. 415-455
-
-
Bernheimer, H.1
Birkmayer, W.2
Hornykiewicz, O.3
-
4
-
-
73049129373
-
The effect of L-3,4-dihydroxyphenylalanine (DOPA) on akinesia in Parkinson's syndrome
-
Birkmeyer W., Hornykiewicz O. The effect of L-3,4-dihydroxyphenylalanine (DOPA) on akinesia in Parkinson's syndrome. Wein. Klin. Wochenschr. 73:1961;787-788.
-
(1961)
Wein. Klin. Wochenschr.
, vol.73
, pp. 787-788
-
-
Birkmeyer, W.1
Hornykiewicz, O.2
-
5
-
-
0028238804
-
Wearing-off fluctuations in Parkinson's disease: Contributions of postsynaptic mechanisms
-
Bravi D., Mouradian M.D., Roberts J.W., Davis T.L., Sohn Y.H., Chase T.N. Wearing-off fluctuations in Parkinson's disease contributions of postsynaptic mechanisms. Ann. Neurol. 36:1994;27-31.
-
(1994)
Ann. Neurol.
, vol.36
, pp. 27-31
-
-
Bravi, D.1
Mouradian, M.D.2
Roberts, J.W.3
Davis, T.L.4
Sohn, Y.H.5
Chase, T.N.6
-
6
-
-
0032889986
-
Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: Studies on medial forebrain bundle and striatal lesions
-
Chang J.W., Wachtel S.R., Young D., Kang U.J. Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease Studies on medial forebrain bundle and striatal lesions. Neuroscience. 88:1999;617-628.
-
(1999)
Neuroscience
, vol.88
, pp. 617-628
-
-
Chang, J.W.1
Wachtel, S.R.2
Young, D.3
Kang, U.J.4
-
7
-
-
0031954732
-
Levodopa therapy: Consequences of the nonphysiologic replacement of dopamine
-
Chase T.N. Levodopa therapy consequences of the nonphysiologic replacement of dopamine. Neurology. 50:1998;S17-S25.
-
(1998)
Neurology
, vol.50
-
-
Chase, T.N.1
-
8
-
-
0029920096
-
Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: Implications for the pathogenesis of the on-off phenomenon
-
Colosimo C., Merello M., Hughes A.J., Sieradzan K., Lees A.J. Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease implications for the pathogenesis of the on-off phenomenon. J. Neurol. Neurosurg. Psychiatry. 61:1996;634-637.
-
(1996)
J. Neurol. Neurosurg. Psychiatry
, vol.61
, pp. 634-637
-
-
Colosimo, C.1
Merello, M.2
Hughes, A.J.3
Sieradzan, K.4
Lees, A.J.5
-
9
-
-
0026765992
-
Kinetic-dynamic relationship of oral levodopa: Possible biphasic response after sequential doses in Parkinson's disease
-
Contin M., Riva R., Martinelli P., Baruzzi A. Kinetic-dynamic relationship of oral levodopa possible biphasic response after sequential doses in Parkinson's disease. Mov. Disord. 7:1992;244-248.
-
(1992)
Mov. Disord.
, vol.7
, pp. 244-248
-
-
Contin, M.1
Riva, R.2
Martinelli, P.3
Baruzzi, A.4
-
10
-
-
0027477017
-
Pharmacodynamic modeling of oral levodopa: Clinical application in Parkinson's disease
-
Contin M., Riva R., Martinelli P., Cortelli P., Albani F., Baruzzi A. Pharmacodynamic modeling of oral levodopa clinical application in Parkinson's disease. Neurology. 43:1993;367-371.
-
(1993)
Neurology
, vol.43
, pp. 367-371
-
-
Contin, M.1
Riva, R.2
Martinelli, P.3
Cortelli, P.4
Albani, F.5
Baruzzi, A.6
-
11
-
-
0027930341
-
Longitudinal monitoring of the levodopa concentration-effect relationship in Parkinson's disease
-
Contin M., Riva R., Martinelli P., Cortelli P., Albani F., Baruzzi A. Longitudinal monitoring of the levodopa concentration-effect relationship in Parkinson's disease. Neurology. 44:1994;1287-1292.
-
(1994)
Neurology
, vol.44
, pp. 1287-1292
-
-
Contin, M.1
Riva, R.2
Martinelli, P.3
Cortelli, P.4
Albani, F.5
Baruzzi, A.6
-
12
-
-
0014673226
-
Modification of parkinsonism: Chronic treatment with L-dopa
-
Cotzias G.C., Papavasiliou P.S., Gellene R. Modification of parkinsonism chronic treatment with L-dopa. N. Engl. J. Med. 280:1969;337-345.
-
(1969)
N. Engl. J. Med.
, vol.280
, pp. 337-345
-
-
Cotzias, G.C.1
Papavasiliou, P.S.2
Gellene, R.3
-
13
-
-
0014700327
-
Similarities between neurologic effects of L-DOPA and of apomorphine
-
Cotzias G.C., Papavasilious P.S., Fehling C., Kaufman B., Mena I. Similarities between neurologic effects of L-DOPA and of apomorphine. N. Engl. J. Med. 282:1970;31-33.
-
(1970)
N. Engl. J. Med.
, vol.282
, pp. 31-33
-
-
Cotzias, G.C.1
Papavasilious, P.S.2
Fehling, C.3
Kaufman, B.4
Mena, I.5
-
15
-
-
0034855583
-
Early morning off-medication dyskinesias, dystonia, and choreic subtypes
-
Cubo E., Gracies J.M., Benabou R., Olanow C.W., Raman R., Leurgans S., Goetz C.G. Early morning off-medication dyskinesias, dystonia, and choreic subtypes. Arch. Neurol. 58:2001;1379-1382.
-
(2001)
Arch. Neurol.
, vol.58
, pp. 1379-1382
-
-
Cubo, E.1
Gracies, J.M.2
Benabou, R.3
Olanow, C.W.4
Raman, R.5
Leurgans, S.6
Goetz, C.G.7
-
16
-
-
0032946972
-
Dopamine autoreceptor function is lost in advanced Parkinson's disease
-
Ekesbo A., Rydin E., Torstenson R., Sydow O., Laengstrom B., Tedroff J. Dopamine autoreceptor function is lost in advanced Parkinson's disease. Neurology. 52:1999;120-125.
-
(1999)
Neurology
, vol.52
, pp. 120-125
-
-
Ekesbo, A.1
Rydin, E.2
Torstenson, R.3
Sydow, O.4
Laengstrom, B.5
Tedroff, J.6
-
17
-
-
0023762236
-
Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, Part I
-
Fabbrini G., Mouradian M.M., Juncos J.L., Schlegel J., Mohr E., Chase T.N. Motor fluctuations in Parkinson's disease central pathophysiological mechanisms, Part I. Ann. Neurol. 24:1988;366-371.
-
(1988)
Ann. Neurol.
, vol.24
, pp. 366-371
-
-
Fabbrini, G.1
Mouradian, M.M.2
Juncos, J.L.3
Schlegel, J.4
Mohr, E.5
Chase, T.N.6
-
18
-
-
0031715932
-
Concentration-response relationship of levodopa in patients at different stages of Parkinson's disease
-
Harder S., Baas H. Concentration-response relationship of levodopa in patients at different stages of Parkinson's disease. Clin. Pharmacol. Ther. 64:1998;183-191.
-
(1998)
Clin. Pharmacol. Ther.
, vol.64
, pp. 183-191
-
-
Harder, S.1
Baas, H.2
-
19
-
-
0021142576
-
On-off fluctuations in Parkinson's disease: A clinical and neuropharmacological study
-
Hardie R.J., Lees A.J., Stern G.M. On-off fluctuations in Parkinson's disease a clinical and neuropharmacological study. Brain. 107:1984;487-506.
-
(1984)
Brain
, vol.107
, pp. 487-506
-
-
Hardie, R.J.1
Lees, A.J.2
Stern, G.M.3
-
20
-
-
0036764810
-
Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease
-
Hauser R.A., Holford N.H. Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease. Mov Disord. 17:2002;961-968.
-
(2002)
Mov Disord.
, vol.17
, pp. 961-968
-
-
Hauser, R.A.1
Holford, N.H.2
-
21
-
-
0016268257
-
The mechanisms of action of L-Dopa in Parkinson's disease
-
Hornykiewicz O. The mechanisms of action of L-Dopa in Parkinson's disease. Life. Sci. 15:1974;1249-1259.
-
(1974)
Life. Sci.
, vol.15
, pp. 1249-1259
-
-
Hornykiewicz, O.1
-
22
-
-
0024405531
-
Continuous and intermittent levodopa differentially affect basal ganglia function
-
Juncos J.L., Engber T.M., Raisman R., Susel Z., Thibaut F., Ploska A., Agid Y., Chase T.N. Continuous and intermittent levodopa differentially affect basal ganglia function. Ann. Neurol. 25:1989;473-478.
-
(1989)
Ann. Neurol.
, vol.25
, pp. 473-478
-
-
Juncos, J.L.1
Engber, T.M.2
Raisman, R.3
Susel, Z.4
Thibaut, F.5
Ploska, A.6
Agid, Y.7
Chase, T.N.8
-
23
-
-
0036460942
-
Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: Results of a two-year, prospective follow-up
-
Kanovsky P., Kubova D., Bares M., Hortova H., Streitova H., Rektor I., Znojil V. Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine results of a two-year, prospective follow-up. Mov. Disord. 17:2002;188-191.
-
(2002)
Mov. Disord.
, vol.17
, pp. 188-191
-
-
Kanovsky, P.1
Kubova, D.2
Bares, M.3
Hortova, H.4
Streitova, H.5
Rektor, I.6
Znojil, V.7
-
25
-
-
0002664244
-
Psychomotor stimulant-induced sensitization: Behavior and neurochemical correlates
-
P.W. Kalivas, & C.D. Barnes. Caldwell, NJ: Telford Press
-
Kuczenski R., Segal D.S. Psychomotor stimulant-induced sensitization behavior and neurochemical correlates. Kalivas P.W., Barnes C.D. Sensitization in the Nervous System. 1988;177-205 Telford Press, Caldwell, NJ.
-
(1988)
Sensitization in the Nervous System
, pp. 177-205
-
-
Kuczenski, R.1
Segal, D.S.2
-
26
-
-
0036869163
-
Beginning-of-dose and rebound worsening in MPTP-treated common marmosets treated with levodopa
-
Kuoppamaki M., Al Barghouthy G., Jackson M., Smith L., Zeng B.Y., Quinn N., Jenner P. Beginning-of-dose and rebound worsening in MPTP-treated common marmosets treated with levodopa. Mov. Disord. 17:2002;1312-1317.
-
(2002)
Mov. Disord.
, vol.17
, pp. 1312-1317
-
-
Kuoppamaki, M.1
Al Barghouthy, G.2
Jackson, M.3
Smith, L.4
Zeng, B.Y.5
Quinn, N.6
Jenner, P.7
-
27
-
-
0345227297
-
The effects of chronic L-DOPA therapy on pharmacodynamic parameters in a rat model of motor response fluctuations
-
Lee, E.A., Lee, W.Y., Kim, Y.S., Kang, U.J., 2003. The effects of chronic L-DOPA therapy on pharmacodynamic parameters in a rat model of motor response fluctuations. Exp. Neurol. 184, 304-312.
-
(2003)
Exp. Neurol.
, vol.184
, pp. 304-312
-
-
Lee, E.A.1
Lee, W.Y.2
Kim, Y.S.3
Kang, U.J.4
-
28
-
-
0026551551
-
Levodopa-induced dyskinesias in Parkinson's disease: Clinical and pharmacological classification
-
Luquin M.R., Scipioni O., Vaamonde J., Gershanik O., Obeso J.A. Levodopa-induced dyskinesias in Parkinson's disease clinical and pharmacological classification. Mov. Disord. 7:1992;117-124.
-
(1992)
Mov. Disord.
, vol.7
, pp. 117-124
-
-
Luquin, M.R.1
Scipioni, O.2
Vaamonde, J.3
Gershanik, O.4
Obeso, J.A.5
-
29
-
-
0033616439
-
Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervated striatum
-
Maeda T., Kannari K., Suda T., Matsunga M. Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervated striatum. Brain. Res. 817:1999;185-191.
-
(1999)
Brain. Res.
, vol.817
, pp. 185-191
-
-
Maeda, T.1
Kannari, K.2
Suda, T.3
Matsunga, M.4
-
30
-
-
0036869028
-
Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long-term follow-up study of 64 patients
-
Manson A.J., Turner K., Lees A.J. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease long-term follow-up study of 64 patients. Mov. Disord. 17:2002;1235-1241.
-
(2002)
Mov. Disord.
, vol.17
, pp. 1235-1241
-
-
Manson, A.J.1
Turner, K.2
Lees, A.J.3
-
31
-
-
0017275668
-
"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy
-
Marsden C.D., Parkes J.D. "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet. 1:1976;292-296.
-
(1976)
Lancet
, vol.1
, pp. 292-296
-
-
Marsden, C.D.1
Parkes, J.D.2
-
32
-
-
0026472109
-
Begining-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease
-
Merello M., Lees A.J. Begining-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 55:1992;1024-1026.
-
(1992)
J. Neurol. Neurosurg. Psychiatry
, vol.55
, pp. 1024-1026
-
-
Merello, M.1
Lees, A.J.2
-
33
-
-
0343580484
-
Effects of suprathreshold levodopa doses on dyskinesia in advanced Parkinson's disease
-
Metman L.V., Van Den Mundkhof P., Klaassen A.A.G., Blanchet P.J., Mouradian M.M., Chase T.N. Effects of suprathreshold levodopa doses on dyskinesia in advanced Parkinson's disease. Neurology. 49:1997;711-713.
-
(1997)
Neurology
, vol.49
, pp. 711-713
-
-
Metman, L.V.1
Van Den Mundkhof, P.2
Klaassen, A.A.G.3
Blanchet, P.J.4
Mouradian, M.M.5
Chase, T.N.6
-
34
-
-
0024347984
-
Pathogenesis of dyskinesia in Parkinson's disease
-
Mouradian M.M., Heuser I.J.E., Baronti F., Fabbrini G., Juncos J.L., Chase T.N. Pathogenesis of dyskinesia in Parkinson's disease. Ann. Neurol. 25:1989;523-526.
-
(1989)
Ann. Neurol.
, vol.25
, pp. 523-526
-
-
Mouradian, M.M.1
Heuser, I.J.E.2
Baronti, F.3
Fabbrini, G.4
Juncos, J.L.5
Chase, T.N.6
-
35
-
-
0023711041
-
Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, Part II
-
Mouradian M.M., Juncos J.L., Fabbrini G., Schlegel J., Bartko J.J., Chase T.N. Motor fluctuations in Parkinson's disease central pathophysiological mechanisms, Part II. Ann. Neurol. 24:1988;372-378.
-
(1988)
Ann. Neurol.
, vol.24
, pp. 372-378
-
-
Mouradian, M.M.1
Juncos, J.L.2
Fabbrini, G.3
Schlegel, J.4
Bartko, J.J.5
Chase, T.N.6
-
36
-
-
0017468670
-
Patterns of dystonia ("I-D-I" and "D-I-D") in response to L-Dopa therapy for Parkinson's disease
-
Muenter M.D., Sharpless N.S., Tyce G.M., Darley F.L. Patterns of dystonia ("I-D-I" and "D-I-D") in response to L-Dopa therapy for Parkinson's disease. Mayo Clin. Proc. 52:1977;163-174.
-
(1977)
Mayo Clin. Proc.
, vol.52
, pp. 163-174
-
-
Muenter, M.D.1
Sharpless, N.S.2
Tyce, G.M.3
Darley, F.L.4
-
37
-
-
0015043830
-
L-DOPA therapy of Parkinson's disease: Plasma L-DOPA concentration, therapeutic response, and side effects
-
Muenter M.D., Tyce G.M. L-DOPA therapy of Parkinson's disease plasma L-DOPA concentration, therapeutic response, and side effects. Mayo Clin. Proc. 46:1971;231-239.
-
(1971)
Mayo Clin. Proc.
, vol.46
, pp. 231-239
-
-
Muenter, M.D.1
Tyce, G.M.2
-
38
-
-
0033962207
-
Apomorphine can sustain the long-duration response to L-DOPA in fluctuating PD
-
Nutt J.G., Carter J.H. Apomorphine can sustain the long-duration response to L-DOPA in fluctuating PD. Neurology. 54:2000;247-250.
-
(2000)
Neurology
, vol.54
, pp. 247-250
-
-
Nutt, J.G.1
Carter, J.H.2
-
39
-
-
0036264465
-
Evolution of the response to levodopa during the first 4 years of therapy
-
Nutt J.G., Carter J.H., Lea E.S., Sexton G.J. Evolution of the response to levodopa during the first 4 years of therapy. Ann. Neurol. 51:2002;686-693.
-
(2002)
Ann. Neurol.
, vol.51
, pp. 686-693
-
-
Nutt, J.G.1
Carter, J.H.2
Lea, E.S.3
Sexton, G.J.4
-
40
-
-
0030799456
-
Short- and long-duration responses to levodopa during the first year of levodopa therapy
-
Nutt J.G., Carter J.H., Van Houten L., Woodward W.R. Short- and long-duration responses to levodopa during the first year of levodopa therapy. Ann. Neurol. 42:1997;349-355.
-
(1997)
Ann. Neurol.
, vol.42
, pp. 349-355
-
-
Nutt, J.G.1
Carter, J.H.2
Van Houten, L.3
Woodward, W.R.4
-
41
-
-
0023729233
-
Does an inhibitory action of levodopa contribute to motor fluctuations?
-
Nutt J.G., Gancher S.T., Woodward W.R. Does an inhibitory action of levodopa contribute to motor fluctuations? Neurology. 38:1988;1553-1557.
-
(1988)
Neurology
, vol.38
, pp. 1553-1557
-
-
Nutt, J.G.1
Gancher, S.T.2
Woodward, W.R.3
-
42
-
-
0029883235
-
The response to levodopa in Parkinson's disease: Imposing pharmacological law and order
-
Nutt J.G., Holford N.H.G. The response to levodopa in Parkinson's disease imposing pharmacological law and order. Ann. Neurol. 39:1996;561-573.
-
(1996)
Ann. Neurol.
, vol.39
, pp. 561-573
-
-
Nutt, J.G.1
Holford, N.H.G.2
-
43
-
-
0035960647
-
Interactions between deep brain stimulation and levodopa in Parkinson's disease
-
Nutt J.G., Rufener S.L., Carter J.H., Anderson V.C., Pahwa R., Hammerstad J.P., Burchiel K.J. Interactions between deep brain stimulation and levodopa in Parkinson's disease. Neurology. 57:2001;1835-1842.
-
(2001)
Neurology
, vol.57
, pp. 1835-1842
-
-
Nutt, J.G.1
Rufener, S.L.2
Carter, J.H.3
Anderson, V.C.4
Pahwa, R.5
Hammerstad, J.P.6
Burchiel, K.J.7
-
44
-
-
0022443805
-
Levodopa pharmacokinetics and pharmacodynamics in fluctuating parkinsonian patients
-
Nutt J.G., Woodward W.R. Levodopa pharmacokinetics and pharmacodynamics in fluctuating parkinsonian patients. Neurology. 36:1986;739-744.
-
(1986)
Neurology
, vol.36
, pp. 739-744
-
-
Nutt, J.G.1
Woodward, W.R.2
-
45
-
-
0026480977
-
Effect of long-term therapy on the pharmacodynamics of levodopa: Relation to on-off phenomenon
-
Nutt J.G., Woodward W.R., Carter J.H., Gancher S.T. Effect of long-term therapy on the pharmacodynamics of levodopa relation to on-off phenomenon. Arch. Neurol. 49:1992;1123-1130.
-
(1992)
Arch. Neurol.
, vol.49
, pp. 1123-1130
-
-
Nutt, J.G.1
Woodward, W.R.2
Carter, J.H.3
Gancher, S.T.4
-
46
-
-
0021674129
-
Dopamine metabolism in the central nervous system after discontinuation of L-dopa therapy in patients with Parkinsons disease
-
Ogasahara S., Nishikawa Y., Takahashi M., Wada K., Nakamura Y., Yorifuji S., Tarul S. Dopamine metabolism in the central nervous system after discontinuation of L-dopa therapy in patients with Parkinsons disease. J. Neurol. Sci. 66:1984;151-163.
-
(1984)
J. Neurol. Sci.
, vol.66
, pp. 151-163
-
-
Ogasahara, S.1
Nishikawa, Y.2
Takahashi, M.3
Wada, K.4
Nakamura, Y.5
Yorifuji, S.6
Tarul, S.7
-
47
-
-
0034069554
-
Preventing levodopa-induced dyskinesias
-
Olanow C.W., Obeso J.A. Preventing levodopa-induced dyskinesias. Ann. Neurol. 47:2000;S167-S176.
-
(2000)
Ann. Neurol.
, vol.47
-
-
Olanow, C.W.1
Obeso, J.A.2
-
48
-
-
0029064091
-
Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test
-
Olsson M., Nikkah G., Bentlage C., Bjorklund A. Forelimb akinesia in the rat Parkinson model differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J. Neurosci. 15:1995;3863-3875.
-
(1995)
J. Neurosci.
, vol.15
, pp. 3863-3875
-
-
Olsson, M.1
Nikkah, G.2
Bentlage, C.3
Bjorklund, A.4
-
49
-
-
0022446286
-
L-Dopa: How it may exacerbate parkinsonian symptoms
-
Paalzow G.H.M., Paalzow L.K. L-Dopa how it may exacerbate parkinsonian symptoms. Trends Pharmacol. Sci. 9:1986;15-19.
-
(1986)
Trends Pharmacol. Sci.
, vol.9
, pp. 15-19
-
-
Paalzow, G.H.M.1
Paalzow, L.K.2
-
50
-
-
0028046229
-
Motor fluctuations in levodopa treated parkinsonian rats: Relation to lesion extent and treatment duration
-
Papa S.M., Eengber T.M., Kask A.M., ChaseE T.N. Motor fluctuations in levodopa treated parkinsonian rats relation to lesion extent and treatment duration. Brain Res. 662:1994;69-74.
-
(1994)
Brain Res.
, vol.662
, pp. 69-74
-
-
Papa, S.M.1
Eengber, T.M.2
Kask, A.M.3
Chasee, T.N.4
-
51
-
-
0034935182
-
L-Dopa induces dyskinesia in normal monkeys: Behavioural and pharmacokinetic observations
-
Pearce R.K., Heikkila M., Linden I.B., Jenner P. L-Dopa induces dyskinesia in normal monkeys behavioural and pharmacokinetic observations. Psychopharmacology (Berlin). 156:2001;402-409.
-
(2001)
Psychopharmacology (Berlin)
, vol.156
, pp. 402-409
-
-
Pearce, R.K.1
Heikkila, M.2
Linden, I.B.3
Jenner, P.4
-
52
-
-
0023787423
-
Dystonia in Parkinson's disease: Clinical and pharmacological features
-
Poewe W.H., Lees A.J., Stern G.M. Dystonia in Parkinson's disease clinical and pharmacological features. Ann. Neurol. 23:1988;73-78.
-
(1988)
Ann. Neurol.
, vol.23
, pp. 73-78
-
-
Poewe, W.H.1
Lees, A.J.2
Stern, G.M.3
-
53
-
-
0019151790
-
Intermittent versus continuous stimulation: Effect of time interval on the development of sensitization or tolerance
-
Post R.M. Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance. Life. Sci. 26:1980;1275-1282.
-
(1980)
Life. Sci.
, vol.26
, pp. 1275-1282
-
-
Post, R.M.1
-
54
-
-
0028126712
-
Regulation by DZ dopamine receptors of in vivo dopamaine synthesis in striata of rats and mice with experimental parkinsonism
-
Richard M.G., Bennett J.P. Regulation by DZ dopamine receptors of in vivo dopamaine synthesis in striata of rats and mice with experimental parkinsonism. Exp. Neurol. 129:1994;57-63.
-
(1994)
Exp. Neurol.
, vol.129
, pp. 57-63
-
-
Richard, M.G.1
Bennett, J.P.2
-
55
-
-
23444448248
-
Levodopa peak response time reflects severity of dopamine neuron loss in Parkinson's disease
-
Sohn Y.H., Metman L.V., Bravi D., Linfante I., Aotsuka A., Mouradian M.M., Chase T.N. Levodopa peak response time reflects severity of dopamine neuron loss in Parkinson's disease. Neurology. 44:1994;755-757.
-
(1994)
Neurology
, vol.44
, pp. 755-757
-
-
Sohn, Y.H.1
Metman, L.V.2
Bravi, D.3
Linfante, I.4
Aotsuka, A.5
Mouradian, M.M.6
Chase, T.N.7
-
56
-
-
0036723589
-
Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease
-
Stocchi F., Ruggieri S., Vacca L., Olanow C.W. Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease. Brain. 125:2002;2058-2066.
-
(2002)
Brain
, vol.125
, pp. 2058-2066
-
-
Stocchi, F.1
Ruggieri, S.2
Vacca, L.3
Olanow, C.W.4
-
57
-
-
0014954919
-
DOPA effects on motility in mice: Potentiation by MK 485 and dexchlorpheniramine
-
Stromberg U. DOPA effects on motility in mice potentiation by MK 485 and dexchlorpheniramine. Psychopharmacology. 18:1970;58-67.
-
(1970)
Psychopharmacology
, vol.18
, pp. 58-67
-
-
Stromberg, U.1
-
58
-
-
0034898907
-
Levodopa induces dyskinesias in normal squirrel monkeys
-
Togasaki D.M., Tan L., Protell P., Di Monte D.A., Quik M., Langston J.W. Levodopa induces dyskinesias in normal squirrel monkeys. Ann. Neurol. 50:2001;254-257.
-
(2001)
Ann. Neurol.
, vol.50
, pp. 254-257
-
-
Togasaki, D.M.1
Tan, L.2
Protell, P.3
Di Monte, D.A.4
Quik, M.5
Langston, J.W.6
-
59
-
-
0030182863
-
Dose-related effects of continuous levodopa infusion in rats with unilateral lesions of the substantia nigra
-
Trugman J.M., Hubbard C.A., Bennett J.P. Dose-related effects of continuous levodopa infusion in rats with unilateral lesions of the substantia nigra. Brain Res. 725:1996;177-183.
-
(1996)
Brain Res.
, vol.725
, pp. 177-183
-
-
Trugman, J.M.1
Hubbard, C.A.2
Bennett, J.P.3
-
60
-
-
0033546661
-
Pharmacodynamics of the long-duration response to levodopa in PD
-
Zappia M., Bosco D., Plastino M., Nicoletti G., Branca D., Oliveri R., Aguglia U., Gambardella A., Quattrone A. Pharmacodynamics of the long-duration response to levodopa in PD. Neurology. 53:1999;557-560.
-
(1999)
Neurology
, vol.53
, pp. 557-560
-
-
Zappia, M.1
Bosco, D.2
Plastino, M.3
Nicoletti, G.4
Branca, D.5
Oliveri, R.6
Aguglia, U.7
Gambardella, A.8
Quattrone, A.9
-
61
-
-
0023730012
-
Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage
-
Zhang W.Q., Tilson H.A., Nanry K.P., Hudson P.M., Hong J.S., Stachowiak M.K. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage. Brain Res. 461:1988;335-342.
-
(1988)
Brain Res.
, vol.461
, pp. 335-342
-
-
Zhang, W.Q.1
Tilson, H.A.2
Nanry, K.P.3
Hudson, P.M.4
Hong, J.S.5
Stachowiak, M.K.6
|